Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Scarlet Fever

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Scarlet Fever

Salvatore Pardo et al.
Free Books & Documents

Excerpt

Scarlet fever is a syndrome characterized by a blanching, erythematous, maculopapular rash often described as "sandpaper-like," a "strawberry tongue," and exudative pharyngitis (see Image. Scarlet Fever). The causative organism, Streptococcus pyogenes (group A Streptococcus or "GAS"), is a gram-positive bacterium adapted to humans. This organism grows in pairs and chains and is responsible for a range of infections, including superficial, deep, and invasive conditions such as cellulitis, pharyngitis, erysipelas, and necrotizing fasciitis.

GAS produces streptococcal pyrogenic exotoxins (SPEs), which act as superantigens released during infection. These exotoxins are the primary cause of the erythematous rash associated with scarlet fever. GAS bacterial pharyngitis and scarlet fever most commonly affect school-age and adolescent children due to higher transmissibility in school settings. However, these infections can also occur in other age groups, particularly in crowded environments such as households and nursing homes.

Scarlet fever caused by GAS infections can occur at any age. Although it is most commonly associated with GAS pharyngitis, it may also develop with other GAS infections, whether invasive or noninvasive, such as erysipelas or necrotizing fasciitis. Historically, GAS serotypes have displayed cyclic epidemiological patterns. Notably, GAS is among the few bacteria that produce superantigen exotoxins, which are exceptionally potent activators of T cells. GAS superantigens, also referred to as erythrogenic or scarlet fever toxins, are responsible for the characteristic erythematous, sandpaper-like rash and strawberry tongue seen in scarlet fever. Superantigen genes, such as speA, speC, and ssa, enhance the fitness and virulence of GAS, contributing to the development of invasive disease.

Scarlet fever epidemics and invasive GAS infections were common in the 19th century. While the prevalence of scarlet fever declined in the 20th century, a resurgence of GAS infections occurred in the 1980s. In the past decade, more virulent epidemic strains of GAS have emerged, leading to an increase in both GAS infections and scarlet fever. Suppurative and non-suppurative complications can arise from GAS infections, including rheumatic heart disease (RHD) and poststreptococcal glomerulonephritis (PSGN). Prompt treatment of acute infections is essential to prevent these complications.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Salvatore Pardo declares no relevant financial relationships with ineligible companies.

Disclosure: Thomas Perera declares no relevant financial relationships with ineligible companies.

References

    1. Walker MJ, Brouwer S. Scarlet fever makes a comeback. Lancet Infect Dis. 2018 Feb;18(2):128-129. - PubMed
    1. Gera K, McIver KS. Laboratory growth and maintenance of Streptococcus pyogenes (the Group A Streptococcus, GAS). Curr Protoc Microbiol. 2013 Oct 02;30:9D.2.1-9D.2.13. - PMC - PubMed
    1. Cordery R, Purba AK, Begum L, Mills E, Mosavie M, Vieira A, Jauneikaite E, Leung RCY, Siggins MK, Ready D, Hoffman P, Lamagni T, Sriskandan S. Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK. Lancet Microbe. 2022 May;3(5):e366-e375. - PMC - PubMed
    1. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C, Strep-EURO Study Group. Jasir A. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008 Jul;46(7):2359-67. - PMC - PubMed
    1. Shannon BA, McCormick JK, Schlievert PM. Toxins and Superantigens of Group A Streptococci. Microbiol Spectr. 2019 Jan;7(1) - PMC - PubMed

Publication types

LinkOut - more resources